Concepedia

<p>Safety of cetirizine ophthalmic solution 0.24% for the treatment of allergic conjunctivitis in adult and pediatric subjects</p>

Ranjan Malhotra, Edward Meier, Gail Torkildsen, Paul J Gomes, Mark C Jasek

Clinical ophthalmology · 2019 · 13 citations · 8 references

DOIFull text

Open access

Abstract

Cetirizine ophthalmic solution 0.24% dosed BID or TID demonstrated an acceptable safety profile and was well-tolerated when administered to subjects aged ≥2 years.

References

8

Effect of cetirizine on mast cell-mediator release and cellular traffic during the cutaneous late-phase reaction

E.N. Charlesworth, Anne Kagey‐Sobotka, Philip S. Norman et al. · Journal of Allergy and Clinical Immunology · 1989 · 210 citations · Full text

, , +5

Tear and conjunctival changes during the allergen-induced early- and late-phase responses

A S Bacon, Poonam Ahluwalia, Anne‐Marie Irani et al. · Journal of Allergy and Clinical Immunology · 2000 · 132 citations · Full text

, , +7

An evaluation of the ocular drying effects of 2 systemic antihistamines: loratadine and cetirizine hydrochloride

George W Ousler, Katrina A. Wilcox, Gaurav Gupta et al. · Annals of Allergy Asthma & Immunology · 2004 · 69 citations

, , +8

Ocular challenge and hyperresponsiveness to histamine in patients with allergic conjunctivitis

Giorgio Ciprandi, S. Buscaglia, Giampaola Pesce et al. · Journal of Allergy and Clinical Immunology · 1993 · 51 citations

, , +7

Allergic ocular disorders: a spectrum of diseases.

Ehlers Wh, Donshik Pc · ˜The œCLAO journal · 1992 · 35 citations

, , +11